SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001174947-17-000695
Filing Date
2017-04-28
Accepted
2017-04-28 16:17:01
Documents
7
Period of Report
2017-06-08
Effectiveness Date
2017-04-28

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT c464959_def14a.htm DEF 14A 1084489
2 GRAPHIC line.gif GRAPHIC 43
3 GRAPHIC logo_sciclone.jpg GRAPHIC 39311
4 GRAPHIC sig_friedhelm.jpg GRAPHIC 19254
5 GRAPHIC spacer.gif GRAPHIC 43
6 GRAPHIC v464959_pc-1.jpg GRAPHIC 753307
7 GRAPHIC v464959_pc-2.jpg GRAPHIC 688823
  Complete submission text file 0001174947-17-000695.txt   3152777
Mailing Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125
Business Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125 650-358-3456
SCICLONE PHARMACEUTICALS INC (Filer) CIK: 0000880771 (see all company filings)

IRS No.: 943116852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-19825 | Film No.: 17795774
SIC: 2834 Pharmaceutical Preparations